Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

AACR 2016 /
SPF30 sunscreens delay melanoma incidence in preclinical model

16th - 20th Apr 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 26.04.16
Views: 1834

Dr Christin Burd - Ohio State University, Columbus, USA

Dr Christin Burd speaks with ecancertv at AACR 2016 about her research into the potential for SPF30 sunscreen to delay the onset of melanoma.

Though the damaging potential of UVA and UVB radiation has long been known, attitudes in the cosmetic industry (which regulates sun-screen lotion development) are at odds with the animal testing required to prove a direct delay of melanoma onset in UV sensitive knockout mice.

The news article supporting this video can be found here, and it also features in our highlights of the AACR conference.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation